These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and regional mouse brain distribution of [11C]nisoxetine, a norepinephrine uptake inhibitor. Haka MS; Kilbourn MR Int J Rad Appl Instrum B; 1989; 16(8):771-4. PubMed ID: 2533589 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 5-HT3 receptor antagonist [11C]KF17643. Ishiwata K; Saito N; Yanagawa K; Furuta R; Ishii S; Kiyosawa M; Homma Y; Ishii K; Suzuki F; Senda M Nucl Med Biol; 1996 Apr; 23(3):285-90. PubMed ID: 8782238 [TBL] [Abstract][Full Text] [Related]
6. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. Ito H; Nyberg S; Halldin C; Lundkvist C; Farde L J Nucl Med; 1998 Jan; 39(1):208-14. PubMed ID: 9443763 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter. Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892 [TBL] [Abstract][Full Text] [Related]
8. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo. Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand. Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305 [TBL] [Abstract][Full Text] [Related]
10. [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography. Lundkvist C; Halldin C; Ginovart N; Nyberg S; Swahn CG; Carr AA; Brunner F; Farde L Life Sci; 1996; 58(10):PL 187-92. PubMed ID: 8602111 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of 5-HT3 receptor antagonists, [11C]Y-25130 and [11C]YM060. Ishiwata K; Ishii K; Ishii S; Senda M Appl Radiat Isot; 1995 Sep; 46(9):907-10. PubMed ID: 7581293 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biodistribution of [11C]fludiazepam for imaging benzodiazepine receptors. Ishiwata K; Yanai K; Ido T; Miura-Kanno Y; Kawashima K Int J Rad Appl Instrum B; 1988; 15(4):365-71. PubMed ID: 2855634 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 11C-labeled nonpeptide antagonists for cholecystokinin receptors: [11C]L-365,260 and [11C]L-365,346. Haradahira T; Inoue O; Kobayashi K; Suzuki K Nucl Med Biol; 1998 Apr; 25(3):203-8. PubMed ID: 9620624 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of [11C]cyanoimipramine. Hashimoto K; Inoue O; Suzuki K; Yamasaki T; Kojima M Int J Rad Appl Instrum B; 1987; 14(6):587-92. PubMed ID: 3429240 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary evaluation of [11C]NE-100 labeled in two different positions as a PET sigma receptor ligand. Ishiwata K; Noguchi J; Ishii S; Hatano K; Ito K; Nabeshima T; Senda M Nucl Med Biol; 1998 Apr; 25(3):195-202. PubMed ID: 9620623 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein. de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of [11C]MK-912 as an alpha2-adrenergic receptor radioligand for PET studies. Shiue C; Pleus RC; Shiue GG; Rysavy JA; Sunderland JJ; Cornish KG; Young SD; Bylund DB Nucl Med Biol; 1998 Feb; 25(2):127-33. PubMed ID: 9468027 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors. Robertson DW; Bloomquist W; Cohen ML; Reid LR; Schenck K; Wong DT J Med Chem; 1990 Dec; 33(12):3176-81. PubMed ID: 2258903 [TBL] [Abstract][Full Text] [Related]
19. Development of fluorine-18-labeled 5-HT1A antagonists. Lang L; Jagoda E; Schmall B; Vuong BK; Adams HR; Nelson DL; Carson RE; Eckelman WC J Med Chem; 1999 May; 42(9):1576-86. PubMed ID: 10229627 [TBL] [Abstract][Full Text] [Related]
20. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice. Samnick S; Remy N; Ametamey S; Bader JB; Brandau W; Kirsch CM Life Sci; 1998; 63(22):2001-13. PubMed ID: 9839544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]